EGFR c.2314C>A ;(p.P772T)

Variant ID: 7-55249016-C-A

NM_005228.3(EGFR):c.2314C>A;(p.P772T)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology
Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y
Publication Date: 2022

Variant appearance in text: EGFR: 2314C>A; P772T
PubMed Link: 36505399
Variant Present in the following documents:
  • Table_2.xlsx, sheet 3
  • Table_2.xlsx, sheet 2
View BVdb publication page



Clinical and genomic features of Chinese lung cancer patients with germline mutations.

Nature Communications
Peng, Wenying W; Li, Bin B; Li, Jin J; Chang, Lianpeng L; Bai, Jing J; Yi, Yuting Y; Chen, Rongrong R; Zhang, Yanyan Y; Chen, Chen C; Pu, Xingxiang X; Jiang, Meilin M; Li, Jia J; Zhong, Rui R; Xu, Fang F; Chen, Bolin B; Xu, Li L; Wang, Ning N; Huan, Jiaojiao J; Dai, Pingping P; Guan, Yanfang Y; Yang, Ling L; Xia, Xuefeng X; Yi, Xin X; Wang, Jiayin J; Yu, Fenglei F; Wu, Lin L
Publication Date: 2022-03-10

Variant appearance in text: EGFR: 2314C>A; P772T
PubMed Link: 35273153
Variant Present in the following documents:
  • 41467_2022_28840_MOESM7_ESM.xlsx, sheet 1
View BVdb publication page



Sortilin-related receptor is a druggable therapeutic target in breast cancer.

Molecular Oncology
Al-Akhrass, Hussein H; Pietilä, Mika M; Lilja, Johanna J; Vesilahti, Ella-Maria EM; Anttila, Johanna M JM; Haikala, Heidi M HM; Munne, Pauliina M PM; Klefström, Juha J; Peuhu, Emilia E; Ivaska, Johanna J
Publication Date: 2021-09-26

Variant appearance in text: EGFR: P772T
PubMed Link: 34564954
Variant Present in the following documents:
  • Main text
  • MOL2-16-116.pdf
View BVdb publication page



Sortilin-related receptor is a druggable therapeutic target in breast cancer.

Molecular Oncology
Al-Akhrass, Hussein H; Pietilä, Mika M; Lilja, Johanna J; Vesilahti, Ella-Maria EM; Anttila, Johanna M JM; Haikala, Heidi M HM; Munne, Pauliina M PM; Klefström, Juha J; Peuhu, Emilia E; Ivaska, Johanna J
Publication Date: 2022-01

Variant appearance in text: EGFR: P772T
PubMed Link: 34564954
Variant Present in the following documents:
  • Main text
  • MOL2-16-116.pdf
View BVdb publication page



Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy.

Genes
Baglivo, Sara S; Bianconi, Fortunato F; Metro, Giulio G; Gili, Alessio A; Tofanetti, Francesca Romana FR; Bellezza, Guido G; Ricciuti, Biagio B; Mandarano, Martina M; Teti, Valeria V; Siggillino, Annamaria A; Reda, Maria Sole MS; Chiari, Rita R; Pistola, Lorenza L; Sidoni, Angelo A; Minotti, Vincenzo V; Roila, Fausto F; Ludovini, Vienna V
Publication Date: 2021-06-29

Variant appearance in text: EGFR: P772T
PubMed Link: 34209514
Variant Present in the following documents:
  • Main text
  • genes-12-00992.pdf
View BVdb publication page